Company news

H. Lundbeck A/S news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

June 24, 2025

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

June 21, 2025

Calls

The 5 newest of 10 calls. Every call is listed under its year.

Decks

The 5 newest of 64 decks. Every deck is listed under its year.